Virica Awarded NIIMBL Project to Enhance CAR-T Manufacturing
Virica has been selected as a project lead for one of NIIMBL | The National Institute for Innovation in Manufacturing Biopharmaceuticals planned projects, which aim to address key opportunities for innovation in biopharmaceutical manufacturing.
NIIMBL is a public-private partnership whose mission is to accelerate biopharmaceutical manufacturing.
Virica, with support from NIIMBL members AstraZeneca and Sartorius Stedim Biotech , aims to increase lentiviral vector production outputs, cut costs, and improve manufacturing efficiency for CAR-T using small-molecule enhancers.
Read NIIMBL’s full press release
The post Virica Awarded NIIMBL Project to Enhance CAR-T Manufacturing appeared first on Virica Biotech .
Full content in Virica Biotech